BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15477761)

  • 1. Cyclin proteolysis and CDK inhibitors: two redundant pathways to maintain genome stability in mammalian cells.
    Chibazakura T
    Cell Cycle; 2004 Oct; 3(10):1243-5. PubMed ID: 15477761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107.
    Chibazakura T; McGrew SG; Cooper JA; Yoshikawa H; Roberts JM
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4465-70. PubMed ID: 15070741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivation of cyclin A-CDK induces centrosome overduplication and chromosome tetraploidization in mouse cells.
    Niwa T; Akaike Y; Watanabe K; Chibazakura T
    Biochem Biophys Res Commun; 2021 Apr; 549():91-97. PubMed ID: 33667714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant activation of cyclin A-CDK induces G2/M-phase checkpoint in human cells.
    Akaike Y; Chibazakura T
    Cell Cycle; 2020 Jan; 19(1):84-96. PubMed ID: 31760882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK inhibitors, p21(Cip1) and p27(Kip1), participate in cell cycle exit of mammalian cardiomyocytes.
    Tane S; Ikenishi A; Okayama H; Iwamoto N; Nakayama KI; Takeuchi T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1105-9. PubMed ID: 24380855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of rat postnatal lung alveolar development by glucocorticoids: involvement of the p21CIP1 and p27KIP1 cyclin-dependent kinase inhibitors.
    Corroyer S; Schittny JC; Djonov V; Burri PH; Clement A
    Pediatr Res; 2002 Feb; 51(2):169-76. PubMed ID: 11809910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation.
    Tian JQ; Quaroni A
    Am J Physiol; 1999 Jun; 276(6):C1245-58. PubMed ID: 10362586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
    Schmidt M; Fan Z
    Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation.
    Swadling JB; Warnecke T; Morris KL; Barr AR
    Biophys J; 2022 Jun; 121(12):2312-2329. PubMed ID: 35614852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury.
    Park SK; Kim W; Lee CH; Koh GY
    Nephron; 2000 Nov; 86(3):306-14. PubMed ID: 11096288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.